Antioxidant vitamins and glucose-6-phosphate dehydrogenase deficiency in full-term neonates

Khalid K Abdul-Razzak1, Enaam M Almomany, Mohamad K Nusier

  • 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan. kkalani@just.edu.jo

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency in neonates may not solely cause hyperbilirubinemia through red blood cell hemolysis. Lower antioxidant vitamin levels were observed in G6PD-deficient infants who developed hyperbilirubinemia, but results were not significant.

Area of Science:

  • Biochemistry
  • Neonatology
  • Genetics

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder.
  • G6PD deficiency increases susceptibility to oxidative stress in red blood cells.
  • The exact mechanism linking G6PD deficiency to neonatal hyperbilirubinemia remains unclear.

Purpose of the Study:

  • To investigate the relationship between antioxidant vitamin (E and C) levels and neonatal hyperbilirubinemia in term infants with G6PD deficiency.
  • To explore potential contributing factors to hyperbilirubinemia in G6PD-deficient neonates.

Main Methods:

  • A cohort of 196 neonates was studied, with 12 identified as G6PD deficient.
  • Demographic data, serum total bilirubin, hemoglobin, hematocrit, and plasma levels of vitamins E and C were measured on day one postpartum.
  • Comparison was made between G6PD-deficient neonates who developed hyperbilirubinemia and those who did not.

Main Results:

  • G6PD-deficient neonates who developed hyperbilirubinemia had lower mean serum levels of hemoglobin, hematocrit, vitamin C, and vitamin E compared to those without hyperbilirubinemia.
  • Despite observed differences, none of the measured parameters (including vitamin levels) showed a statistically significant difference between the two groups.
  • Gestational age and birth weight were similar between G6PD-deficient neonates with and without hyperbilirubinemia.

Conclusions:

  • Red blood cell hemolysis due to an insufficient antioxidant system in G6PD-deficient neonates is likely not the sole cause of hyperbilirubinemia.
  • Further research is needed to fully elucidate the multifactorial nature of hyperbilirubinemia in the context of G6PD deficiency.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
Glycolysis: Preparatory Phase01:21

Glycolysis: Preparatory Phase

In cellular metabolism (the complete breakdown of glucose to extract energy),  glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
ATP Energy Storage and Release01:31

ATP Energy Storage and Release

ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...